Memo Therapeutics AG Appoints Frits van Alphen, MD as Chief Development Officer PRESS RELEASE Frits is an industry veteran with a proven track record in nephrology drug development, including the successful development of Velphoro® and Ferinject® at Vifor Pharma Schlieren /...